SummitTX Capital »

Cytokinetics shares owned by SummitTX Capital

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.3M 50k 65.91
2025-03-31 $537k 13k 40.19

More positions owned by SummitTX Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Warner Bros Discovery Com Ser A (WBD)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Asml Hldg Nv N Y Registry Shs (ASML)
MKS Instruments (MKSI)
State Str Spdr S&p Midcap 40 Utser1 S&pdcrp (MDY)
Griffon Corporation (GFF)
Meritage Homes Corporation (MTH)
Cabot Oil & Gas Corporation (CTRA)
Topbuild (BLD)
NVR (NVR)
Cisco Systems (CSCO)
Ge Aerospace Com New (GE)
NVIDIA Corporation (NVDA)

View all positions for SummitTX Capital

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Bank of America Corporation
Susquehanna International
Rtw Investments
Armistice Capital
Goldman Sachs Group
Polar Capital Holdings

View all funds holding Cytokinetics